Interactions with and activation of immune cells by CD41a+ extracellular vesicles

被引：1

作者：

Tamagne, Marie ^{[1
,2
]}

Khelfa, Mehdi ^{[1
,2
]}

Many, Souganya ^{[3
]}

Neyrinck-Leglantier, Deborah ^{[1
,2
]}

Delorme, Adele Silane ^{[1
,2
]}

Pinheiro, Marion Klea ^{[1
,2
]}

Andrieu, Muriel ^{[3
]}

Cleophax, Sabine ^{[2
]}

Pirenne, France ^{[1
,2
]}

Vingert, Benoit ^{[1
,2
]}

机构：

[1] Univ Paris Est Creteil, INSERM, IMRB, Creteil, France

[2] Etab Francais Sang, Ivry, France

[3] Univ Paris Cite, CNRS, Inst Cochin, INSERM U1016,UMR8104, Paris, France

来源：

FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷

关键词：

extracellular vesicles (EVs); immune activation; platelet transfusion; immunomodulation; multi-omic analyses; TRANSFUSION-RELATED IMMUNOMODULATION; PLATELET MICROPARTICLES; CD40; LIGAND; T-CELLS; ANTIGEN; MICROVESICLES; NEUTROPHILS; COMPONENTS; RECEPTOR;

D O I：

10.3389/fimmu.2025.1509078

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Introduction The immunological profiles of CD4+ T lymphocytes (TLs) from patients with hematological malignancies differ between patients who have and have not received transfusions. There may be several reasons for these differences, including the presence of extracellular vesicles (EVs) derived from plasma membrane budding and present in the platelet concentrates. Indeed, EVs can modulate the immune system through interactions with many immune cells, but the underlying mechanisms remain incompletely understood.Methods We therefore investigated how interactions with CD41a+ EVs cause immune cells to change phenotype and function. CD41a+ EVs were cultured with TLs, B lymphocytes, and monocytes. Given the potential involvement of monocytes in leukemia progression, we performed a new original multi-omics study to confirm the protein changes and gene activation observed following interaction with CD41a+ EVsResults The CD41a+ EVs had immunomodulatory effects on all these cell types but this effect depended on the numbers of EVs. CD4+ TLs required large numbers of CD41a+ EVs for activation, whereas monocytes were the most sensitive. With the new multi-omics technique, we confirmed the direct effects of CD41a+ EVs on protein phenotype and gene activation.Conclusion Transfusion EVs should be considered during the immunological follow-up of patients after transfusion to detect immunological effects on malignant hemopathies, and during the development of new immunotherapies.

引用

页数：12

共 74 条

[11]

Coombs J., Ben Hassen L., Leclerc M., Tamagne M., Pannetier L., Khelfa M., Et al., Dominant immune response to HLA-B57/B58 molecules after platelet transfusion, Transfusion, 60, (2020)

[12]

Khelfa M., Leclerc M., Kerbrat S., Boudjemai Y.N.S., Benchouaia M., Neyrinck-Leglantier D., Et al., Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients, Front Immunol, 14, (2023)

[13]

Saris A., Peyron I., van der Meer P.F., Stuge T.B., Zwaginga J.J., van Ham S.M., Et al., Storage-induced platelet apoptosis is a potential risk factor for alloimmunization upon platelet transfusion, Front Immunol, 9, (2018)

[14]

Bang A., Speck E.R., Blanchette V.S., Freedman J., Semple J.W., Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase, Blood, 88, (1996)

[15]

Bang K.W., Speck E.R., Blanchette V.S., Freedman J., Semple J.W., Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens, Blood, 95, (2000)

[16]

Sayeh E., Sterling K., Speck E., Freedman J., Semple J.W., IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells, Blood, 103, (2004)

[17]

Melki I., Tessandier N., Zufferey A., Boilard E., Platelet microvesicles in health and disease, Platelets, 28, (2017)

[18]

Wannez A., Devalet B., Chatelain B., Chatelain C., Dogne J.M., Mullier F., Extracellular vesicles in red blood cell concentrates: an overview, Transfus Med Rev, 33, (2019)

[19]

Kuebler W.M., William N., Post M., Acker J.P., McVey M.J., Extracellular vesicles: effectors of transfusion-related acute lung injury, Am J Physiol Lung Cell Mol Physiol, 325, (2023)

[20]

Schierer S., Ostalecki C., Zinser E., Lamprecht R., Plosnita B., Stich L., Et al., Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC, Life Sci Alliance, 1, (2018)

← 1 2 3 4 5 6 7 8 →